2 - 2 |
New year, new resolution Seijo BC |
3 - 3 |
Braiding a molecular knot Halford B |
4 - 4 |
Aptamer-based sensors work in live animals Arnaud C |
4 - 4 |
Cancer puzzle solved Everts S |
5 - 5 |
Process mimics spider silk spinning Arnaud C |
5 - 5 |
A sweet hookup Halford B |
6 - 7 |
Turning oil paint into a gel helped speed up art Everts S |
6 - 6 |
DFT method closes the gap on predicting band gaps Jacoby M |
6 - 6 |
Nanoparticles suffocate tumors Torrice M |
7 - 7 |
Predicting immune response to protein Cross R |
7 - 7 |
Boron nitride catalyzes olefin hydrogenations Jacoby M |
7 - 7 |
Chromium complex has a long luminescent glow Ritter S |
8 - 8 |
J&J to set up NYC incubator Thayer A |
8 - 8 |
China jails managers for pollution Tremblay JF |
8 - 8 |
"The outcome of the merger is, of course, still very open" [Anonymous] |
9 - 9 |
DuPont will invest in the Experimental Station Tullo A |
9 - 9 |
Healthcare conference brings deal deluge Jarvis L |
10 - 10 |
Allergan targets nerves and the gut Mullin R |
10 - 10 |
Agrimetis raises $23.5 million Bomgardner M |
10 - 10 |
Ghasemi to receive Palladium award Reisch M |
10 - 10 |
DuPont cultivates cheese makers Reisch M |
10 - 10 |
Mitsubishi Rayon buys SGL carbon fiber Reisch M |
10 - 10 |
Air Products wants to buy Yingde Gases Tullo A |
10 - 10 |
Arkema to modernize acrylic acid plant Tullo A |
10 - 11 |
Illumina cuts stake in Grail, strikes deals Thayer A |
11 - 11 |
Daiichi shuts Indian R&D center Tremblay JF |
11 - 11 |
Celgene, Sanofi eye autoimmune disease Jarvis L |
11 - 11 |
Global bioprocessing boost for Merck Scott A |
11 - 11 |
Biotech bigs float R&D venture Mullin R |
12 - 13 |
"I remain convinced that no country is better suited to confront the climate challenge and reap the economic benefits of a low-carbon future than the United States" Taylor A |
12 - 12 |
Beryllium exposure limit finalized Kemsley J |
12 - 12 |
White House updates biotech oversight plans Cross R |
13 - 13 |
Actionable level for PFOA in drinking water lowered Morrison J |
13 - 13 |
Girl sues India to get TB drug Venkatasubramanian KV |
13 - 13 |
Last two US agencies complete open access plans Widener A |
15 - 17 |
Introducing the new "power suit" Halford B |
18 - 19 |
Spotlight grows on antibiotic pollution Tremblay JF |
20 - 21 |
How chemistry programs are moving beyond small molecules Arnaud CH |
22 - 22 |
Trading sleep for results Jobber C |
23 - 23 |
HOW DO EVERGREEN TREES STAY GREEN? [Anonymous] |
25 - 25 |
Uncertainty surrounds federal budget Widener A |
26 - 26 |
TSCA implementation a priority Erickson B |
26 - 26 |
Waste could finally find a home Morrison J |
27 - 27 |
Uncertain path, tumultuous time for energy policy Johnson J |
27 - 27 |
US future in Paris Agreement unclear Johnson J |
28 - 28 |
EPA to decide on several crop protection products Erickson B |
28 - 28 |
Trump signals major shift in import-export policy Hess G |
30 - 30 |
Administration could seek to stop chemical makers' mergers Hogue C |
30 - 30 |
Scrutiny of EPA's scientific review process will continue Morrison J |
30 - 31 |
Immigration reform efforts could impact scientists Widener A |
31 - 31 |
FDA to implement 21st Century Cures law Morrison J |
31 - 31 |
Momentum to boost cosmetics oversight grows Erickson B |
31 - 31 |
Industry continues to seek US ratification of treaty Hogue C |
31 - 31 |
Higher education legislation may gain momentum in 2017 Widener A |
32 - 33 |
Are your employee benefits enough? Adams JE |
34 - 35 |
ACS adds policy statement on safety Wang LD |
36 - 36 |
Apply to be a SciFinder Future Leader Wang LD |
40 - 40 |
A talk so bad, it's good [Anonymous] |
40 - 40 |
The National Shrine's molecular mosaic [Anonymous] |